Zai Lab Limited ADR’s filing revealed that its Chief Financial Officer Chen Yajing unloaded Company’s shares for reported $50932.0 on Aug 15 ’25. In the deal valued at $35.42 per share,1,438 shares were sold. As a result of this transaction, Chen Yajing now holds 16,720 shares worth roughly $0.6 million.
Then, Edmondson Frazor Titus III bought 1,883 shares, generating $68,233 in total proceeds.
Before that, Smiley Joshua L bought 6,641 shares. Zai Lab Limited ADR shares valued at $240,645 were divested by the Officer at a price of $36.24 per share.
Scotiabank initiated its Zai Lab Limited ADR [ZLAB] rating to a Sector outperform in a research note published on March 07, 2025; the price target was $55. A number of analysts have revised their coverage, including BofA Securities’s analysts, who decreased its forecast for the stock in early March from “a Buy” to “a Neutral”. Morgan Stanley began covering ZLAB with “an Overweight” recommendation on December 14, 2023. Cantor Fitzgerald started covering the stock on August 10, 2023. It rated ZLAB as “an Overweight”.
Price Performance Review of ZLAB
On Monday, Zai Lab Limited ADR [NASDAQ:ZLAB] saw its stock fall -0.11% to $35.69. Over the last five days, the stock has gained 2.97%. Zai Lab Limited ADR shares have risen nearly 119.63% since the year began. Nevertheless, the stocks have risen 36.27% over the past one year. While a 52-week high of $44.34 was reached on 06/12/25, a 52-week low of $16.41 was recorded on 01/15/25.
Levels Of Support And Resistance For ZLAB Stock
The 24-hour chart illustrates a support level at 35.24, which if violated will result in even more drops to 34.80. On the upside, there is a resistance level at 36.45. A further resistance level may holdings at 37.22.
How much short interest is there in Zai Lab Limited ADR?
A steep rise in short interest was recorded in Zai Lab Limited ADR stocks on 2025-07-31, growing by 0.52 million shares to a total of 4.57 million shares. Yahoo Finance data shows the prior-month short interest on 2025-06-30 was 4.05 million shares. There was a rise of 11.41%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on January 21, 2022 when Macquarie began covering the stock and recommended ‘”an Outperform”‘ rating along with a $64 price target.
